Publication
Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: results from the NeoALTTO phase III clinical trial
Journal Paper/Review - Jul 28, 2021
Venet David, Gomez Henry, Semiglazov Vladimir, de Azambuja Evandro, Huober Jens, Nuciforo Paolo, Di Cosimo Serena, Piccart-Gebhart Martine, Loi Sherene, Rothé Françoise, Saura Cristina, Wang Yingbo, Rediti Mattia, Maetens Marion, Fumagalli Debora, Brown David N, Majjaj Samira, Salgado Roberto, Pusztai Lajos, Harbeck Nadia, El-Abed Sarra, Sotiriou Christos
Venet, David
6
0
Rediti, Mattia
2
0
Maetens, Marion
4
0
Fumagalli, Debora
10
0
Brown, David N
1
0
Majjaj, Samira
3
0
Salgado, Roberto
5
0
Pusztai, Lajos
6
0
Harbeck, Nadia
38
0
El-Abed, Sarra
7
0
Wang, Yingbo
5
0
Saura, Cristina
6
0
Gomez, Henry
4
0
Semiglazov, Vladimir
2
0
de Azambuja, Evandro
17
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Nuciforo, Paolo
11
0
Di Cosimo, Serena
21
0
Piccart-Gebhart, Martine
5
0
Loi, Sherene
8
0